| HIPS | SCD | HIPS / SCD | |
| Gain YTD | -1.320 | -5.127 | 26% |
| Net Assets | 113M | 377M | 30% |
| Total Expense Ratio | 1.60 | 1.33 | 120% |
| Turnover | 43.00 | 44.00 | 98% |
| Yield | 10.91 | 2.55 | 429% |
| Fund Existence | 11 years | 22 years | - |
| HIPS | SCD | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 89% | 3 days ago 90% |
| Stochastic ODDS (%) | 3 days ago 66% | 3 days ago 90% |
| Momentum ODDS (%) | 3 days ago 86% | 3 days ago 79% |
| MACD ODDS (%) | 3 days ago 90% | 3 days ago 68% |
| TrendWeek ODDS (%) | 3 days ago 81% | 3 days ago 89% |
| TrendMonth ODDS (%) | 3 days ago 65% | 3 days ago 78% |
| Advances ODDS (%) | 4 days ago 81% | 3 days ago 90% |
| Declines ODDS (%) | 17 days ago 66% | 10 days ago 83% |
| BollingerBands ODDS (%) | 3 days ago 84% | 3 days ago 90% |
| Aroon ODDS (%) | 3 days ago 69% | 3 days ago 77% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HSLAX | 42.13 | 0.60 | +1.44% |
| Hartford Small Cap Growth A | |||
| TWRCX | 54.45 | 0.47 | +0.87% |
| American Century Growth C | |||
| PWDIX | 10.39 | 0.09 | +0.87% |
| Donoghue Forlines Dividend I | |||
| FTDZX | 169.55 | 0.80 | +0.47% |
| Franklin Biotechnology Discovery Adv | |||
| HFYRX | 13.42 | 0.05 | +0.37% |
| Hartford Schroders Intl Multi-Cp Val R3 | |||
A.I.dvisor tells us that SCD and BX have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCD and BX's prices will move in lockstep.
| Ticker / NAME | Correlation To SCD | 1D Price Change % | ||
|---|---|---|---|---|
| SCD | 100% | +0.54% | ||
| BX - SCD | 11% Poorly correlated | -0.25% | ||
| AAPL - SCD | 9% Poorly correlated | +1.25% | ||
| ET - SCD | 8% Poorly correlated | -0.71% | ||
| OKE - SCD | 8% Poorly correlated | -1.65% | ||
| MSFT - SCD | 4% Poorly correlated | +0.59% | ||
More | ||||